Cerecetam
Piracetam tablets for cognitive impairment and myoclonus. It is one of the oldest nootropic medicines, first developed in the 1960s.
Cerecetam details
- Conditions
- Cognitive Impairment · Myoclonus
- Alternative names
- piracetam
- Therapeutic class
- Nootropic
- Pharmacological class
- GABA Derivative
- Known off-label uses
- dyslexia
- Contraindications
- severe renal impairment; huntington's chorea; cerebral haemorrhage
- Minor side effects
- nervousness; hyperkinesia; weight gain
- Moderate side effects
- insomnia; somnolence; depression
- Serious side effects
- severe bleeding disorder, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Intas Pharmaceuticals
- Onset Time
- 30–60 minutes
- Duration
- 6–8 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Thyroid Hormones; Warfarin
- Age restrictions
- Approved for adults and select paediatric populations.
Patient summary
Piracetam tablets for cognitive impairment and myoclonus. It is one of the oldest nootropic medicines, first developed in the 1960s.
Mechanism of action
Modulates neurotransmission pathways and improves membrane fluidity of neuronal cells, optimising neuroplasticity.
Pregnancy and breastfeeding
Pregnancy: Avoid during pregnancy as safety is unconfirmed. Breastfeeding: Avoid.